Evidence map›Paper›PMID 35414597›Full record

ArticleCMAJ open

Household transmission of SARS-CoV-2 from unvaccinated asymptomatic and symptomatic household members with confirmed SARS-CoV-2 infection: an antibody-surveillance study.

Maala Bhatt, Amy C Plint, Ken Tang, Richard Malley, Anne Pham Huy, Candice McGahern, Jennifer Dawson, Martin Pelchat, Lauren Dawson, Terry Varshney and 7 more

Abstract read
In one paragraph

Article in CMAJ open. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. The role of children in household transmission of COVID-19: a systematic review and meta-analysis.International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases · 2022
    Pooled it
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Autoantibodies targeting angiotensin-converting enzyme 2 are prevalent and not induced by SARS-CoV-2 infection.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2025
    Article
  9. Article
  10. Household Transmission Dynamics of Asymptomatic SARS-CoV-2-Infected Children: A Multinational, Controlled Case-Ascertained Prospective Study.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2024
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Limited role of children in transmission of SARS-CoV-2 virus in households-Immunological analysis of 26 familial clusters.Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology · 2023
    Article
  17. Article
  18. Article
  19. Cohort profile:BMJ open · 2022
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Maala BhattDepartment of Pediatrics (Bhatt, Plint, Pham Huy, Varshney, Thampi, Alnaji, Zemek), Children's Hospital of Eastern Ontario, University of Ottawa; Department of Emergency Medicine (Plint, Alnaji, Zemek), University of Ottawa; Children's Hospital of Eastern Ontario Research Institute (Tang, McGahern, J. Dawson, L. Dawson, Austin), Ottawa, Ont.; Division of Infectious Diseases (Malley), Boston Children's Hospital and Harvard Medical School, Boston, Mass.; Department of Biochemistry, Microbiology and Immunology (Pelchat, Arnold, Galipeau, Langlois), Faculty of Medicine, University of Ottawa; University of Ottawa Centre for Infection, Immunity and Inflammation (Pelchat, Langlois); Ottawa Hospital Research Institute (Austin), Ottawa, Ont. mbhatt@cheo.on.ca.
Amy C PlintDepartment of Pediatrics (Bhatt, Plint, Pham Huy, Varshney, Thampi, Alnaji, Zemek), Children's Hospital of Eastern Ontario, University of Ottawa; Department of Emergency Medicine (Plint, Alnaji, Zemek), University of Ottawa; Children's Hospital of Eastern Ontario Research Institute (Tang, McGahern, J. Dawson, L. Dawson, Austin), Ottawa, Ont.; Division of Infectious Diseases (Malley), Boston Children's Hospital and Harvard Medical School, Boston, Mass.; Department of Biochemistry, Microbiology and Immunology (Pelchat, Arnold, Galipeau, Langlois), Faculty of Medicine, University of Ottawa; University of Ottawa Centre for Infection, Immunity and Inflammation (Pelchat, Langlois); Ottawa Hospital Research Institute (Austin), Ottawa, Ont.
Ken TangDepartment of Pediatrics (Bhatt, Plint, Pham Huy, Varshney, Thampi, Alnaji, Zemek), Children's Hospital of Eastern Ontario, University of Ottawa; Department of Emergency Medicine (Plint, Alnaji, Zemek), University of Ottawa; Children's Hospital of Eastern Ontario Research Institute (Tang, McGahern, J. Dawson, L. Dawson, Austin), Ottawa, Ont.; Division of Infectious Diseases (Malley), Boston Children's Hospital and Harvard Medical School, Boston, Mass.; Department of Biochemistry, Microbiology and Immunology (Pelchat, Arnold, Galipeau, Langlois), Faculty of Medicine, University of Ottawa; University of Ottawa Centre for Infection, Immunity and Inflammation (Pelchat, Langlois); Ottawa Hospital Research Institute (Austin), Ottawa, Ont.
Richard MalleyDepartment of Pediatrics (Bhatt, Plint, Pham Huy, Varshney, Thampi, Alnaji, Zemek), Children's Hospital of Eastern Ontario, University of Ottawa; Department of Emergency Medicine (Plint, Alnaji, Zemek), University of Ottawa; Children's Hospital of Eastern Ontario Research Institute (Tang, McGahern, J. Dawson, L. Dawson, Austin), Ottawa, Ont.; Division of Infectious Diseases (Malley), Boston Children's Hospital and Harvard Medical School, Boston, Mass.; Department of Biochemistry, Microbiology and Immunology (Pelchat, Arnold, Galipeau, Langlois), Faculty of Medicine, University of Ottawa; University of Ottawa Centre for Infection, Immunity and Inflammation (Pelchat, Langlois); Ottawa Hospital Research Institute (Austin), Ottawa, Ont.
Anne Pham HuyDepartment of Pediatrics (Bhatt, Plint, Pham Huy, Varshney, Thampi, Alnaji, Zemek), Children's Hospital of Eastern Ontario, University of Ottawa; Department of Emergency Medicine (Plint, Alnaji, Zemek), University of Ottawa; Children's Hospital of Eastern Ontario Research Institute (Tang, McGahern, J. Dawson, L. Dawson, Austin), Ottawa, Ont.; Division of Infectious Diseases (Malley), Boston Children's Hospital and Harvard Medical School, Boston, Mass.; Department of Biochemistry, Microbiology and Immunology (Pelchat, Arnold, Galipeau, Langlois), Faculty of Medicine, University of Ottawa; University of Ottawa Centre for Infection, Immunity and Inflammation (Pelchat, Langlois); Ottawa Hospital Research Institute (Austin), Ottawa, Ont.
Candice McGahernDepartment of Pediatrics (Bhatt, Plint, Pham Huy, Varshney, Thampi, Alnaji, Zemek), Children's Hospital of Eastern Ontario, University of Ottawa; Department of Emergency Medicine (Plint, Alnaji, Zemek), University of Ottawa; Children's Hospital of Eastern Ontario Research Institute (Tang, McGahern, J. Dawson, L. Dawson, Austin), Ottawa, Ont.; Division of Infectious Diseases (Malley), Boston Children's Hospital and Harvard Medical School, Boston, Mass.; Department of Biochemistry, Microbiology and Immunology (Pelchat, Arnold, Galipeau, Langlois), Faculty of Medicine, University of Ottawa; University of Ottawa Centre for Infection, Immunity and Inflammation (Pelchat, Langlois); Ottawa Hospital Research Institute (Austin), Ottawa, Ont.
Jennifer DawsonDepartment of Pediatrics (Bhatt, Plint, Pham Huy, Varshney, Thampi, Alnaji, Zemek), Children's Hospital of Eastern Ontario, University of Ottawa; Department of Emergency Medicine (Plint, Alnaji, Zemek), University of Ottawa; Children's Hospital of Eastern Ontario Research Institute (Tang, McGahern, J. Dawson, L. Dawson, Austin), Ottawa, Ont.; Division of Infectious Diseases (Malley), Boston Children's Hospital and Harvard Medical School, Boston, Mass.; Department of Biochemistry, Microbiology and Immunology (Pelchat, Arnold, Galipeau, Langlois), Faculty of Medicine, University of Ottawa; University of Ottawa Centre for Infection, Immunity and Inflammation (Pelchat, Langlois); Ottawa Hospital Research Institute (Austin), Ottawa, Ont.
Martin PelchatDepartment of Pediatrics (Bhatt, Plint, Pham Huy, Varshney, Thampi, Alnaji, Zemek), Children's Hospital of Eastern Ontario, University of Ottawa; Department of Emergency Medicine (Plint, Alnaji, Zemek), University of Ottawa; Children's Hospital of Eastern Ontario Research Institute (Tang, McGahern, J. Dawson, L. Dawson, Austin), Ottawa, Ont.; Division of Infectious Diseases (Malley), Boston Children's Hospital and Harvard Medical School, Boston, Mass.; Department of Biochemistry, Microbiology and Immunology (Pelchat, Arnold, Galipeau, Langlois), Faculty of Medicine, University of Ottawa; University of Ottawa Centre for Infection, Immunity and Inflammation (Pelchat, Langlois); Ottawa Hospital Research Institute (Austin), Ottawa, Ont.
Lauren DawsonDepartment of Pediatrics (Bhatt, Plint, Pham Huy, Varshney, Thampi, Alnaji, Zemek), Children's Hospital of Eastern Ontario, University of Ottawa; Department of Emergency Medicine (Plint, Alnaji, Zemek), University of Ottawa; Children's Hospital of Eastern Ontario Research Institute (Tang, McGahern, J. Dawson, L. Dawson, Austin), Ottawa, Ont.; Division of Infectious Diseases (Malley), Boston Children's Hospital and Harvard Medical School, Boston, Mass.; Department of Biochemistry, Microbiology and Immunology (Pelchat, Arnold, Galipeau, Langlois), Faculty of Medicine, University of Ottawa; University of Ottawa Centre for Infection, Immunity and Inflammation (Pelchat, Langlois); Ottawa Hospital Research Institute (Austin), Ottawa, Ont.
Terry VarshneyDepartment of Pediatrics (Bhatt, Plint, Pham Huy, Varshney, Thampi, Alnaji, Zemek), Children's Hospital of Eastern Ontario, University of Ottawa; Department of Emergency Medicine (Plint, Alnaji, Zemek), University of Ottawa; Children's Hospital of Eastern Ontario Research Institute (Tang, McGahern, J. Dawson, L. Dawson, Austin), Ottawa, Ont.; Division of Infectious Diseases (Malley), Boston Children's Hospital and Harvard Medical School, Boston, Mass.; Department of Biochemistry, Microbiology and Immunology (Pelchat, Arnold, Galipeau, Langlois), Faculty of Medicine, University of Ottawa; University of Ottawa Centre for Infection, Immunity and Inflammation (Pelchat, Langlois); Ottawa Hospital Research Institute (Austin), Ottawa, Ont.
Corey ArnoldDepartment of Pediatrics (Bhatt, Plint, Pham Huy, Varshney, Thampi, Alnaji, Zemek), Children's Hospital of Eastern Ontario, University of Ottawa; Department of Emergency Medicine (Plint, Alnaji, Zemek), University of Ottawa; Children's Hospital of Eastern Ontario Research Institute (Tang, McGahern, J. Dawson, L. Dawson, Austin), Ottawa, Ont.; Division of Infectious Diseases (Malley), Boston Children's Hospital and Harvard Medical School, Boston, Mass.; Department of Biochemistry, Microbiology and Immunology (Pelchat, Arnold, Galipeau, Langlois), Faculty of Medicine, University of Ottawa; University of Ottawa Centre for Infection, Immunity and Inflammation (Pelchat, Langlois); Ottawa Hospital Research Institute (Austin), Ottawa, Ont.
Yannick GalipeauDepartment of Pediatrics (Bhatt, Plint, Pham Huy, Varshney, Thampi, Alnaji, Zemek), Children's Hospital of Eastern Ontario, University of Ottawa; Department of Emergency Medicine (Plint, Alnaji, Zemek), University of Ottawa; Children's Hospital of Eastern Ontario Research Institute (Tang, McGahern, J. Dawson, L. Dawson, Austin), Ottawa, Ont.; Division of Infectious Diseases (Malley), Boston Children's Hospital and Harvard Medical School, Boston, Mass.; Department of Biochemistry, Microbiology and Immunology (Pelchat, Arnold, Galipeau, Langlois), Faculty of Medicine, University of Ottawa; University of Ottawa Centre for Infection, Immunity and Inflammation (Pelchat, Langlois); Ottawa Hospital Research Institute (Austin), Ottawa, Ont.
Michael AustinDepartment of Pediatrics (Bhatt, Plint, Pham Huy, Varshney, Thampi, Alnaji, Zemek), Children's Hospital of Eastern Ontario, University of Ottawa; Department of Emergency Medicine (Plint, Alnaji, Zemek), University of Ottawa; Children's Hospital of Eastern Ontario Research Institute (Tang, McGahern, J. Dawson, L. Dawson, Austin), Ottawa, Ont.; Division of Infectious Diseases (Malley), Boston Children's Hospital and Harvard Medical School, Boston, Mass.; Department of Biochemistry, Microbiology and Immunology (Pelchat, Arnold, Galipeau, Langlois), Faculty of Medicine, University of Ottawa; University of Ottawa Centre for Infection, Immunity and Inflammation (Pelchat, Langlois); Ottawa Hospital Research Institute (Austin), Ottawa, Ont.
Nisha ThampiDepartment of Pediatrics (Bhatt, Plint, Pham Huy, Varshney, Thampi, Alnaji, Zemek), Children's Hospital of Eastern Ontario, University of Ottawa; Department of Emergency Medicine (Plint, Alnaji, Zemek), University of Ottawa; Children's Hospital of Eastern Ontario Research Institute (Tang, McGahern, J. Dawson, L. Dawson, Austin), Ottawa, Ont.; Division of Infectious Diseases (Malley), Boston Children's Hospital and Harvard Medical School, Boston, Mass.; Department of Biochemistry, Microbiology and Immunology (Pelchat, Arnold, Galipeau, Langlois), Faculty of Medicine, University of Ottawa; University of Ottawa Centre for Infection, Immunity and Inflammation (Pelchat, Langlois); Ottawa Hospital Research Institute (Austin), Ottawa, Ont.
Fuad AlnajiDepartment of Pediatrics (Bhatt, Plint, Pham Huy, Varshney, Thampi, Alnaji, Zemek), Children's Hospital of Eastern Ontario, University of Ottawa; Department of Emergency Medicine (Plint, Alnaji, Zemek), University of Ottawa; Children's Hospital of Eastern Ontario Research Institute (Tang, McGahern, J. Dawson, L. Dawson, Austin), Ottawa, Ont.; Division of Infectious Diseases (Malley), Boston Children's Hospital and Harvard Medical School, Boston, Mass.; Department of Biochemistry, Microbiology and Immunology (Pelchat, Arnold, Galipeau, Langlois), Faculty of Medicine, University of Ottawa; University of Ottawa Centre for Infection, Immunity and Inflammation (Pelchat, Langlois); Ottawa Hospital Research Institute (Austin), Ottawa, Ont.
Marc-André LangloisDepartment of Pediatrics (Bhatt, Plint, Pham Huy, Varshney, Thampi, Alnaji, Zemek), Children's Hospital of Eastern Ontario, University of Ottawa; Department of Emergency Medicine (Plint, Alnaji, Zemek), University of Ottawa; Children's Hospital of Eastern Ontario Research Institute (Tang, McGahern, J. Dawson, L. Dawson, Austin), Ottawa, Ont.; Division of Infectious Diseases (Malley), Boston Children's Hospital and Harvard Medical School, Boston, Mass.; Department of Biochemistry, Microbiology and Immunology (Pelchat, Arnold, Galipeau, Langlois), Faculty of Medicine, University of Ottawa; University of Ottawa Centre for Infection, Immunity and Inflammation (Pelchat, Langlois); Ottawa Hospital Research Institute (Austin), Ottawa, Ont.
Roger L ZemekDepartment of Pediatrics (Bhatt, Plint, Pham Huy, Varshney, Thampi, Alnaji, Zemek), Children's Hospital of Eastern Ontario, University of Ottawa; Department of Emergency Medicine (Plint, Alnaji, Zemek), University of Ottawa; Children's Hospital of Eastern Ontario Research Institute (Tang, McGahern, J. Dawson, L. Dawson, Austin), Ottawa, Ont.; Division of Infectious Diseases (Malley), Boston Children's Hospital and Harvard Medical School, Boston, Mass.; Department of Biochemistry, Microbiology and Immunology (Pelchat, Arnold, Galipeau, Langlois), Faculty of Medicine, University of Ottawa; University of Ottawa Centre for Infection, Immunity and Inflammation (Pelchat, Langlois); Ottawa Hospital Research Institute (Austin), Ottawa, Ont.

Funding

CIHR VR2-172722
6 · The paper itself

Abstract

backgroundHousehold transmission contributes to SARS-CoV-2 spread, but the role of children in transmission is unclear. We conducted a study that included symptomatic and asymptomatic children and adults exposed to SARS-CoV-2 in their households with the objective of determining how SARS-CoV-2 is transmitted within households.

methodsIn this case-ascertained antibody-surveillance study, we enrolled households in Ottawa, Ontario, in which at least 1 household member had tested positive for SARS-CoV-2 on reverse transcription polymerase chain reaction testing. The enrolment period was September 2020 to March 2021. Potentially eligible participants were identified if they had tested positive for SARS-CoV-2 at an academic emergency department or affiliated testing centre; people who learned about the study through the media could also self-identify for participation. At least 2 participants were required for a household to be eligible for study participation, and at least 1 enrolled participant per household had to be a child (age < 18 yr). Enzyme-linked immunosorbent assays were used to evaluate SARS-CoV-2-specific IgA, IgM and IgG against the spike-trimer and nucleocapsid protein. The primary outcome was household secondary attack rate, defined as the proportion of household contacts positive for SARS-CoV-2 antibody among the total number of household contacts participating in the study. We performed descriptive statistics at both the individual and household levels. To estimate and compare outcomes between patient subgroups, and to examine predictors of household transmission, we fitted a series of multivariable logistic regression with robust standard errors to account for clustering of individuals within households.

resultsWe enrolled 695 participants from 180 households: 180 index participants (74 children, 106 adults) and 515 of their household contacts (266 children, 249 adults). A total of 487 household contacts (94.6%) (246 children, 241 adults) had SARS-CoV-2 antibody testing, of whom 239 had a positive result (secondary attack rate 49.1%, 95% confidence interval [CI] 42.9%-55.3%). Eighty-eight (36.8%, 95% CI 29.3%-43.2%) of the 239 were asymptomatic; asymptomatic rates were similar for children (51/130 [39.2%, 95% CI 30.7%-48.5%]) and adults (37/115 [32.2%, 95% CI 24.2%-41.4%]) (odds ratio [OR] 1.3, 95% CI 0.8-2.1). Adults were more likely than children to transmit SARS-CoV-2 (OR 2.2, 95% CI 1.3-3.6). The odds of transmission from asymptomatic (OR 0.6, 95% CI 0.2-1.4) versus symptomatic (OR 0.9, 95% CI 0.6-1.4) index participants to household contacts was uncertain. Predictors of household transmission included household density (number of people per bedroom), relationship to index participant and number of cases in the household.

interpretationThe rate of SARS-CoV-2 transmission within households was nearly 50% during the study period, and children were an important source of spread. The findings suggest that children are an important driver of the COVID-19 pandemic; this should inform public health policy.

Indexed as

COVID-19AdultAntibodies, ViralChildFamily CharacteristicsHumansIncidencePandemicsSARS-CoV-2Antibodies, Viral

Identifiers

PMID35414597
PMCPMC9007444

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.